Deficient G6PD activity is well examined in red blood cells (RBC), as it often results in clinical manifestation of mild to severe haemolytic anaemia following exposure to various oxidative agents such as certain drugs [1]. The gene discussed is G6PD; the disease is non-autoimmune hemolytic anemia.